Medicare Enrolled

Dr. Nirav Chiniwalla, MD

Gastroenterology · Concord, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1070 VINEHAVEN DR, Concord, NC 28025
7047831840
In practice since 2006 (20 years)
NPI: 1114955291 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chiniwalla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chiniwalla? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chiniwalla

Dr. Nirav Chiniwalla is a gastroenterology specialist in Concord, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chiniwalla performed 781 Medicare services across 708 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chiniwalla received a total of $10,212 from 49 pharmaceutical and/or device companies across 554 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chiniwalla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 31% volume in NC $10,212 industry payments

Medicare Practice Summary

Medicare Utilization ↗
781
Medicare services
Top 31% in NC for gastroenterology
708
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
191 $83 $200
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
113 $73 $772
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
82 $99 $227
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
77 $198 $1,181
Dilation of esophagus 67 $30 $357
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
64 $104 $265
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
50 $59 $123
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
29 $95 $1,050
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
25 $76 $671
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
20 $176 $879
Endoscopic removal of bile or pancreatic duct stone
A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts.
17 $56 $1,356
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
17 $171 $879
Pancreatic or bile duct stent insertion
A flexible endoscope is used to place a stent into the pancreatic or bile duct to keep it open.
15 $337 $923
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
14 $112 $879
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.9% high complexity
27.9% medium
70.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,212
Total received (2018-2024)
Avg $1,459/year across 7 years
Top 17% in NC for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
554
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,192 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,278
2023
$1,848
2022
$1,595
2021
$1,765
2020
$640
2019
$1,008
2018
$1,078

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$485
Takeda Pharmaceuticals U.S.A., Inc.
$241
Gilead Sciences, Inc.
$223
AIMMUNE THERAPEUTICS, INC.
$165
Madrigal Pharmaceuticals
$158
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$141
Janssen Biotech, Inc.
$130
Alnylam Pharmaceuticals Inc.
$129
E.R. Squibb & Sons, L.L.C.
$113
Lilly USA, LLC
$90
GENZYME CORPORATION
$73
IRONWOOD PHARMACEUTICALS, INC
$61
PFIZER INC.
$48
Fresenius Kabi USA, LLC
$35
Regeneron Healthcare Solutions, Inc.
$30
QOL Medical, LLC
$29
Organon Llc
$24
Phathom Pharmaceuticals, Inc.
$24
Ardelyx, Inc.
$22
Alcresta Therapeutics, Inc.
$21
Ferring Pharmaceuticals Inc.
$21
Merck Sharp & Dohme LLC
$17
Top 3 companies account for 41.7% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,368
Gilead Sciences, Inc.
$1,033
AbbVie Inc.
$793
Janssen Biotech, Inc.
$780
ABBVIE INC.
$711
Takeda Pharmaceuticals U.S.A., Inc.
$615
Alnylam Pharmaceuticals Inc.
$527
PFIZER INC.
$394
AbbVie, Inc.
$393
QOL Medical, LLC
$336
Intercept Pharmaceuticals, Inc.
$252
E.R. Squibb & Sons, L.L.C.
$250
Ferring Pharmaceuticals Inc.
$236
GENZYME CORPORATION
$210
Ironwood Pharmaceuticals, Inc
$176
AIMMUNE THERAPEUTICS, INC.
$165
Nestle HealthCare Nutrition Inc.
$164
Madrigal Pharmaceuticals
$158
Boston Scientific Corporation
$154
BOSTON SCIENTIFIC CORPORATION
$116
Ardelyx, Inc.
$107
Amgen Inc.
$105
UCB, Inc.
$94
Lilly USA, LLC
$90
Merck Sharp & Dohme Corporation
$89
Regeneron Healthcare Solutions, Inc.
$88
IRONWOOD PHARMACEUTICALS, INC
$77
Merck Sharp & Dohme LLC
$67
Celgene Corporation
$64
INTERCEPT PHARMACEUTICALS, INC.
$63
INTRA-SANA LABORATORIES
$46
RedHill Biopharma Inc.
$45
Organon LLC
$44
VIVUS LLC
$39
Synergy Pharmaceuticals Inc
$38
Evoke Pharma, Inc.
$37
Fresenius Kabi USA, LLC
$35
NESTLE HEALTHCARE NUTRITION INC.
$34
Shire North American Group Inc
$25
Braintree Laboratories, Inc.
$25
Organon Llc
$24
Phathom Pharmaceuticals, Inc.
$24
Alcresta Therapeutics, Inc.
$21
Alexion Pharmaceuticals, Inc.
$21
Celltrion USA Inc.
$21
Alfasigma USA, Inc.
$17
Covidien LP
$16
EVOKE PHARMA, INC.
$16
Romark Laboratories, LC
$9
Top 3 companies account for 31.3% of all-time payments
Associated products mentioned in payments ›
APRISO · AVSOLA · Alinia Tablets 500mg 30 count bottle · Bravo · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · Entyvio · GATTEX · GIMOTI · GIVLAARI · HADLIMA · HUMIRA · Humira · IBSRELA · IDACIO · INFLECTRA · Kanuma · LINZESS · Linzess · MAVYRET · Mavyret · Motegrity · Movantik · OCALIVA · OMVOH · PREPOPIK · QSYMIA · Qsymia · REBYOTA · RELIZORB · RELTONE 200 MG · REMICADE · RENFLEXIS · RESMETIROM · REZDIFFRA · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUTAB · Sucraid · TREMFYA · TRULANCE · Trulance · UCERIS TABLETS · VIBERZI · VOQUEZNA · VOWST · WATCHMAN · WATCHMAN Access System · XELJANZ · XIFAXAN · YUFLYMA · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in Concord?
Compare gastroenterologists in the Concord area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
65
Per 100K population
28.1
County median income
$86,084
Nearest hospital
CAROLINAS MEDICAL CENTER-NORTHEAST
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chiniwalla is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of NC peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chiniwalla experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chiniwalla performed 191 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chiniwalla receive payments from pharmaceutical companies?
Yes. Dr. Chiniwalla received a total of $10,212 from 49 companies across 554 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chiniwalla's costs compare to other gastroenterologists in Concord?
Dr. Chiniwalla's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chiniwalla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →